Send to

Choose Destination
J Pediatr Gastroenterol Nutr. 2008 Feb;46(2):226-7. doi: 10.1097/MPG.0b013e318156e139.

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Colombel JF, Sandborn WJ, Rutgeerts P et al. Gastroenterology 2007;132:52-65.

Author information

Department of Paediatric Gastroenterology, Booth Hall Children's Hospital, Manchester, UK.

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center